Elsevier

The Lancet

Volume 376, Issue 9751, 30 October–5 November 2010, Pages 1446-1448
The Lancet

Comment
A counterfeit drug treaty: great idea, wrong implementation

https://doi.org/10.1016/S0140-6736(10)61416-XGet rights and content

First page preview

First page preview
Click to open first page preview

References (11)

  • A Mullard

    EU Implicated in controversial counterfeiting bill

    Lancet

    (2010)
  • MEDICRIME: draft Council of Europe Convention on counterfeiting of medical products and similar crimes involving threats to public health

  • R Cockburn et al.

    The global threat of counterfeit drugs: why industry and governments must communicate the dangers

    PLoS Med

    (2005)
  • AM Dondorp et al.

    Fake antimalarials in southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials

    Trop Med Int Health

    (2004)
  • A Attaran et al.

    Why and how to make an international crime of medicine counterfeiting

There are more references available in the full text version of this article.

Cited by (12)

  • Forensic intelligence for medicine anti-counterfeiting

    2015, Forensic Science International
    Citation Excerpt :

    Society at large is also economically threatened [3,6,7]. There are several reasons for the development of the phenomenon, like the difficulty in agreeing on a definition of medicine counterfeiting and huge deficiencies in legislation and enforcement [3,8–11]. Furthermore counterfeiting is financially rewarding and largely risk-free [1].

  • Understanding and fighting the medicine counterfeit market

    2014, Journal of Pharmaceutical and Biomedical Analysis
    Citation Excerpt :

    Nevertheless the proposed definitions cause controversy. The Council seems to focus more on IP than on public health problems [10,11,58,59]. According to Attaran et al., medicine counterfeiting should even be considered an “international crime”.

  • Countering the problem of falsified and substandard drugs

    2013, Countering the Problem of Falsified and Substandard Drugs
View all citing articles on Scopus
View full text